Table of Contents

1 Industry Overview

• 1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Benign Prostatic Hyperplasia (BPH) Drugs
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Benign Prostatic Hyperplasia (BPH) Drugs Market by Type

• 3.1 By Type
  • 3.1.1 Alpha-blocker
  • 3.1.2 Phosphodiesterase Type-5 Inhibitors
  • 3.1.3 5-alpha-Reductase Inhibitors
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Benign Prostatic Hyperplasia (BPH) Drugs Astellas Pharma (Company Profile, Sales Data etc.)

• 4.2 Eli Lilly (Company Profile, Sales Data etc.)
• 4.3 GlaxoSmithKline (Company Profile, Sales Data etc.)
• 4.4 Sanofi (Company Profile, Sales Data etc.)
• 4.5 ADC Therapeutics (Company Profile, Sales Data etc.)
• 4.6 Bayer HealthCare (Company Profile, Sales Data etc.)
• 4.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
• 4.8 Valeant Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.9 Endo Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.10 Foresee Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.11 Madrigal Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.12 Merck (Company Profile, Sales Data etc.)
• 4.13 Novartis (Company Profile, Sales Data etc.)
• 4.14 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.15 Takeda Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.16 Teva (Company Profile, Sales Data etc.)
• 4.17 Advaxis (Company Profile, Sales Data etc.)
• 4.18 ANI Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.19 BHR Pharma (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospitals
  • 6.1.2 Demand in Clinics
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Benign Prostatic Hyperplasia (BPH) Drugs

Table Application Segment of Benign Prostatic Hyperplasia (BPH) Drugs

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Alpha-blocker

Table Major Company List of Phosphodiesterase Type-5 Inhibitors

Table Major Company List of 5-alpha-Reductase Inhibitors

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2013-2018, by Type, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2013-2018, by Type, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2019-2024, by Type, in Volume

Table Astellas Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ADC Therapeutics Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ADC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer HealthCare Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Valeant Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Endo Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Foresee Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Madrigal Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Spectrum Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Advaxis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ANI Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BHR Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Company, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Benign Prostatic Hyperplasia (BPH) Drugs Production 2013-2018, by Region, in USD Million

Table Benign Prostatic Hyperplasia (BPH) Drugs Production 2013-2018, by Region, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2013-2018, by Region, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2013-2018, by Region, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share 2013-2018, by Region, in Volume

Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in Volume

Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2013-2018, by Country, in Volume

Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration, in 2018

Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs MMarket Concentration, in 2018

Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration, in 2018

Figure Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration, in 2018

Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Hospitals, 2013-2018, in USD Million

Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Hospitals, 2013-2018, in Volume

Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Clinics, 2013-2018, in USD Million

Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Clinics, 2013-2018, in Volume

Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Others, 2013-2018, in USD Million

Figure Benign Prostatic Hyperplasia (BPH) Drugs Demand in Others, 2013-2018, in Volume

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Benign Prostatic Hyperplasia (BPH) Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Benign Prostatic Hyperplasia (BPH) Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Alpha-blocker
Phosphodiesterase Type-5 Inhibitors
5-alpha-Reductase Inhibitors
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Bayer HealthCare
Bristol-Myers Squibb
Valeant Pharmaceuticals
Endo Pharmaceuticals
Foresee Pharmaceuticals
Madrigal Pharmaceuticals
Merck
Novartis
Spectrum Pharmaceuticals
Takeda Pharmaceuticals
Teva
Advaxis
ANI Pharmaceuticals
BHR Pharma
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)